GOLASEPT ANT ORO 20CPR 1,3MG

GOLASEPT ANTISETTIO OROFARING 1.3 MG COMPRESSE

active ingredients

Active ingredient: One tablet contains: cetilpiridinium chloride 1,3 mg Eccipients: sucrose For the full list of excipients see paragraph 6.1

Excellent

Arabic rubber, magnesium stearate, natural aroma of mint, sucrose.

Therapeutic indications

Disinfection of the oral mucosa.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients. Do not use in children under 12 years, unless otherwise prescribed.

Population

One tablet dissolved in the mouth every 2–3 hours, with a maximum of 8 tablets per day. Do not exceed the recommended doses.

Conservation

This medicine does not require any special condition for conservation

Warnings

Do not use for prolonged treatments; after short period of treatment without appreciable results, consult the Doctor. The use, especially if prolonged, of products for topical use can give rise to phenomena of sensitization; in such case, stop treatment and consult your doctor to establish suitable therapy. The product contains sucrose: this is taken into account in diabetic patients and patients who follow hypocaloric dietary regimes. Patients with rare hereditary problems of fructose intolerance, glucose–galactose mal absorption, or isomaltase sucrasis failure, should not take this medicine.

Interactions

Avoid the contemporary use of other antiseptics and detergents.

Effects

In some cases, local intolerance may occur (e.g. burning and irritation). During clinical studies were sporadically reported: transitional irritation of gums, nausea, vomiting, abdominal pain, stomatitis, alteration of taste, slight discoloration of teeth, allergic dermatitis.

Overdosing

No overdose cases have been reported. Symptoms of intoxication, resulting in ingestion of significant amounts of quaternary ammonia compounds, include nausea, vomiting, dispnea, cyanosis, asphyxiation resulting in paralysis of respiratory muscles, SNC depression, hypotension and coma. In man the lethal dose is about 1–3 g. Treatment is symptomatic: administer, if necessary, lenitives. Avoid emesis and gastric lavender.

There is no data regarding the use of cetilpiridinium chloride in pregnant women. In pregnant women and during breastfeeding, the medicine should be administered in case of actual need and under the direct control of the Medic.

Source: Farmadati